Malaria and curable sexually transmitted and reproductive tract coinfection among pregnant women in rural Burkina Faso.
Bacterial vaginosis
Burkina Faso
Chlamydia
Coinfection
Malaria
Pregnancy
Syphilis
Journal
Tropical medicine and health
ISSN: 1348-8945
Titre abrégé: Trop Med Health
Pays: Japan
ID NLM: 101215093
Informations de publication
Date de publication:
04 Nov 2021
04 Nov 2021
Historique:
received:
04
08
2021
accepted:
27
10
2021
entrez:
5
11
2021
pubmed:
6
11
2021
medline:
6
11
2021
Statut:
epublish
Résumé
Malaria and sexually transmitted/reproductive tract infections (STI/RTI) are leading and preventable causes of low birthweight in sub-Saharan Africa. Reducing their impact on pregnancy outcomes requires efficient interventions that can be easily integrated into the antenatal care package. The paucity of data on malaria and STI/RTI coinfection, however, limits efforts to control these infections. This study aimed to determine the prevalence and associated factors of malaria and STI/RTI coinfection among pregnant women in rural Burkina Faso. A cross-sectional survey was conducted among 402 pregnant women attending antenatal clinics at the Yako health district. Sociodemographic and behavioral data were collected, and pregnant women were tested for peripheral malaria by microscopy. Hemoglobin levels were also measured by spectrophotometry and curable bacterial STI/RTI were tested on cervico-vaginal swabs using rapid diagnostic test for chlamydia and syphilis, and Gram staining for bacterial vaginosis. A multivariate logistic regression model was used to assess the association of malaria and STI/RTI coinfection with the characteristics of included pregnant women. The prevalence of malaria and at least one STI/RTI coinfection was 12.9% (95% confidence interval, CI: [9.8-16.7]), malaria and bacterial vaginosis coinfection was 12.2% (95% CI: [9.3-15.9]), malaria and chlamydial coinfection was 1.6% (95% CI: [0.6-3.8]). No coinfection was reported for malaria and syphilis. The individual prevalence was 17.2%, 7.2%, 0.6%, 67.7% and 73.3%, respectively, for malaria infection, chlamydia, syphilis, bacterial vaginosis and STI/RTI combination. Only 10% of coinfections were symptomatic, and thus, 90% of women with coinfection would have been missed by the symptoms-based diagnostic approach. In the multivariate analysis, the first pregnancy (aOR = 2.4 [95% CI: 1.2-4.7]) was the only factor significantly associated with malaria and STI/RTI coinfection. Clinical symptoms were not associated with malaria and STI/RTI coinfection. The prevalence of malaria and curable STI/RTI coinfection was high among pregnant women. The poor performance of the clinical symptoms to predict coinfection suggests that alternative interventions are needed.
Sections du résumé
BACKGROUND
BACKGROUND
Malaria and sexually transmitted/reproductive tract infections (STI/RTI) are leading and preventable causes of low birthweight in sub-Saharan Africa. Reducing their impact on pregnancy outcomes requires efficient interventions that can be easily integrated into the antenatal care package. The paucity of data on malaria and STI/RTI coinfection, however, limits efforts to control these infections. This study aimed to determine the prevalence and associated factors of malaria and STI/RTI coinfection among pregnant women in rural Burkina Faso.
METHODS
METHODS
A cross-sectional survey was conducted among 402 pregnant women attending antenatal clinics at the Yako health district. Sociodemographic and behavioral data were collected, and pregnant women were tested for peripheral malaria by microscopy. Hemoglobin levels were also measured by spectrophotometry and curable bacterial STI/RTI were tested on cervico-vaginal swabs using rapid diagnostic test for chlamydia and syphilis, and Gram staining for bacterial vaginosis. A multivariate logistic regression model was used to assess the association of malaria and STI/RTI coinfection with the characteristics of included pregnant women.
RESULTS
RESULTS
The prevalence of malaria and at least one STI/RTI coinfection was 12.9% (95% confidence interval, CI: [9.8-16.7]), malaria and bacterial vaginosis coinfection was 12.2% (95% CI: [9.3-15.9]), malaria and chlamydial coinfection was 1.6% (95% CI: [0.6-3.8]). No coinfection was reported for malaria and syphilis. The individual prevalence was 17.2%, 7.2%, 0.6%, 67.7% and 73.3%, respectively, for malaria infection, chlamydia, syphilis, bacterial vaginosis and STI/RTI combination. Only 10% of coinfections were symptomatic, and thus, 90% of women with coinfection would have been missed by the symptoms-based diagnostic approach. In the multivariate analysis, the first pregnancy (aOR = 2.4 [95% CI: 1.2-4.7]) was the only factor significantly associated with malaria and STI/RTI coinfection. Clinical symptoms were not associated with malaria and STI/RTI coinfection.
CONCLUSION
CONCLUSIONS
The prevalence of malaria and curable STI/RTI coinfection was high among pregnant women. The poor performance of the clinical symptoms to predict coinfection suggests that alternative interventions are needed.
Identifiants
pubmed: 34736524
doi: 10.1186/s41182-021-00381-5
pii: 10.1186/s41182-021-00381-5
pmc: PMC8567650
doi:
Types de publication
Journal Article
Langues
eng
Pagination
90Informations de copyright
© 2021. The Author(s).
Références
Lancet Glob Health. 2016 Feb;4(2):e98-e108
pubmed: 26795602
Matern Child Nutr. 2016 Oct;12(4):699-712
pubmed: 26373537
Sex Transm Dis. 2008 Dec;35(12):985-9
pubmed: 18779763
Sex Transm Dis. 2015 Jan;42(1):43-7
pubmed: 25504300
Sex Transm Dis. 2012 Nov;39(11):900-1
pubmed: 23060081
Genitourin Med. 1997 Jun;73(3):188-93
pubmed: 9306899
Sex Transm Infect. 2011 Feb;87(1):35-7
pubmed: 20693149
Eur J Obstet Gynecol Reprod Biol. 2020 Dec;255:1-12
pubmed: 33059307
J Infect Dis. 2002 Oct 1;186(7):940-7
pubmed: 12232834
BMC Infect Dis. 2014 Nov 19;14:631
pubmed: 25408152
Sex Transm Infect. 2003 Oct;79(5):375-81
pubmed: 14573832
Lancet Glob Health. 2019 Jun;7(6):e710-e720
pubmed: 31097275
Bull World Health Organ. 2001;79(4):301-5
pubmed: 11357208
J Obstet Gynaecol Can. 2007 Jan;29(1):35-44
pubmed: 17346476
Am J Trop Med Hyg. 2010 Dec;83(6):1212-20
pubmed: 21118924
Curr Infect Dis Rep. 2020 Dec;22(12):
pubmed: 33814990
Lancet. 2013 Aug 3;382(9890):417-425
pubmed: 23746775
BMC Pregnancy Childbirth. 2021 Jan 30;21(1):98
pubmed: 33516183
BMC Med. 2015 Jan 16;13:9
pubmed: 25591391
PLoS One. 2014 Jan 29;9(1):e87510
pubmed: 24489931
PLoS One. 2021 Apr 1;16(4):e0248245
pubmed: 33793584
Am J Trop Med Hyg. 2016 Nov 2;95(5):1069-1076
pubmed: 27672205
BMJ Open. 2017 Dec 29;7(12):e018630
pubmed: 29288183
BMC Pregnancy Childbirth. 2014 Jan 08;14:7
pubmed: 24397463
Obstet Gynecol. 2001 Jul;98(1):79-84
pubmed: 11430961
N Engl J Med. 2005 Sep 22;353(12):1236-44
pubmed: 16177249
PLoS One. 2020 Nov 16;15(11):e0242368
pubmed: 33196665
Am J Obstet Gynecol. 2001 Nov;185(5):1209-17
pubmed: 11717659
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):14-22
pubmed: 18165470
BMC Res Notes. 2016 Mar 29;9:193
pubmed: 27026347
Malar J. 2013 Dec 27;12:464
pubmed: 24373481
J Matern Fetal Neonatal Med. 2018 May;31(9):1227-1233
pubmed: 28423971
JAMA. 2012 May 16;307(19):2079-86
pubmed: 22665107